JAK2 and MPL mutations in myeloproliferative neoplasms: discovery and science.

Abstract excerpt

Although it has long been known that the myeloproliferative neoplasms (MPN) polycythemia vera (PV), essential thrombocythemia (ET) and primary myelofibrosis (PMF) are clonal hematopoietic stem-cell disorders, for many years the genetic basis for these disorders was elusive. A new era in MPN biology began in 2005 with the discovery of a somatic point mutation in JAK2 tyrosine kinase (JAK2V617F), which was...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Gene Dosage
• Share to Genetic Predisposition to Disease
• Share to Janus Kinase 2